NASDAQ:HSDT

Helius Medical Technologies Stock Forecast, Price & News

$15.31

+0.03 (+0.20 %)

(As of 07/27/2021 12:00 AM ET)

Add

Compare

Today's Range

$15.31

▼

$15.31

50-Day Range

$13.28

▼

$17.26

52-Week Range

$11.00

▼

$34.00

Volume369 shs

Average Volume75,517 shs

Market Capitalization$35.47 million

P/E RatioN/A

Dividend YieldN/A

Beta0.84

30 days | 90 days | 365 days | Advanced Chart

Receive HSDT News and Ratings via Email

Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

About Helius Medical Technologies

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.

Financial Survey: Helius Medical Technologies (NASDAQ:HSDT) and Echo Therapeutics (OTCMKTS:ECTE)
July 17, 2021 | americanbankingnews.com

Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT)
July 13, 2021 | nasdaq.com

Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
July 8, 2021 | finance.yahoo.com

Critical Contrast: Escalon Medical (OTCMKTS:ESMC) and Helius Medical Technologies (NASDAQ:HSDT)
July 8, 2021 | americanbankingnews.com

Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics
July 7, 2021 | feeds.benzinga.com

Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
June 30, 2021 | benzinga.com

Helius Medical Tech Names Andreeff as President, CEO >HSDT
June 15, 2021 | marketwatch.com

Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer
June 15, 2021 | finance.yahoo.com

Helius Medical Technologies, Inc. to Participate in Noble Capital Markets’ Virtual Road Show Series
June 8, 2021 | finance.yahoo.com

Helius Medical Technologies A earnings preview: what Wall Street is expecting
May 17, 2021 | markets.businessinsider.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HSDT
Previous Symbol
CUSIPN/A
CIKN/A
Webheliusmedical.com
Phone(215) 944-6100
Employees19
Year FoundedN/A

Sales & Book Value

Annual Sales$660,000.00
Price / Sales53.75
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.58 per share
Price / Book5.93

Profitability

EPS (Most Recent Fiscal Year)($11.80)
Net Income$-14,130,000.00
Net Margins-2,362.52%
Return on Equity-200.84%
Return on Assets-141.72%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares2,317,000
Market Cap$35.47 million
Next Earnings Date8/12/2021 (Confirmed)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.55 out of 5 stars

Medical Sector

864th out of 2,218 stocks

Electromedical Equipment Industry

21st out of 65 stocks

3.3 Analyst's Opinion

Consensus Rating
Helius Medical Technologies has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $20.00, Helius Medical Technologies has a forecasted upside of 30.6% from its current price of $15.31.
Amount of Analyst Coverage
Helius Medical Technologies has received no research coverage in the past 90 days.

3.8 Community Rank

Outperform Votes
Helius Medical Technologies has received 6 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Helius Medical Technologies has received 2 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Helius Medical Technologies has received 75.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Helius Medical Technologies and other stocks. Vote “Outperform” if you believe HSDT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HSDT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Helius Medical Technologies does not currently pay a dividend.
Dividend Growth
Helius Medical Technologies does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.10% of the stock of Helius Medical Technologies is held by insiders.
Percentage Held by Institutions
Only 12.04% of the stock of Helius Medical Technologies is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Helius Medical Technologies are expected to grow in the coming year, from ($6.09) to ($4.55) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Helius Medical Technologies is -1.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Helius Medical Technologies is -1.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Helius Medical Technologies has a P/B Ratio of 5.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Helius Medical Technologies (NASDAQ:HSDT) Frequently Asked Questions

Is Helius Medical Technologies a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Helius Medical Technologies stock.
View analyst ratings for Helius Medical Technologies or view top-rated stocks.

What stocks does MarketBeat like better than Helius Medical Technologies?

Wall Street analysts have given Helius Medical Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Helius Medical Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Helius Medical Technologies' next earnings date?

Helius Medical Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for Helius Medical Technologies.

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies, Inc. (NASDAQ:HSDT) posted its earnings results on Monday, May, 17th. The company reported ($1.65) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.51) by $0.14. The company had revenue of $0.08 million for the quarter, compared to the consensus estimate of $0.09 million. Helius Medical Technologies had a negative trailing twelve-month return on equity of 200.84% and a negative net margin of 2,362.52%.
View Helius Medical Technologies' earnings history.

How has Helius Medical Technologies' stock price been impacted by Coronavirus (COVID-19)?

Helius Medical Technologies' stock was trading at $18.9035 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HSDT shares have decreased by 19.0% and is now trading at $15.31.
View which stocks have been most impacted by COVID-19.

When did Helius Medical Technologies' stock split? How did Helius Medical Technologies' stock split work?

Shares of Helius Medical Technologies reverse split before market open on Thursday, December 31st 2020. The 1-35 reverse split was announced on Thursday, December 31st 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 4th 2021. An investor that had 100 shares of Helius Medical Technologies stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for HSDT?

3 analysts have issued twelve-month price targets for Helius Medical Technologies' shares. Their forecasts range from $20.00 to $20.00. On average, they expect Helius Medical Technologies' share price to reach $20.00 in the next year. This suggests a possible upside of 30.6% from the stock's current price.
View analysts' price targets for Helius Medical Technologies or view top-rated stocks among Wall Street analysts.

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the following people:

Dane Carl Andreeff, President, Chief Executive Officer & Director
Joyce N. LaViscount, Chief Operating Officer & Secretary
Jeffrey S. Mathiesen, Chief Financial Officer & Treasurer
Antonella Favit-Van Pelt, Chief Medical Officer
Frederick Fantazzia, VP-Sales & Marketing North America Region

Who are some of Helius Medical Technologies' key competitors?

Some companies that are related to Helius Medical Technologies include Yubo International Biotech (YBGJ), FONAR (FONR), BioSig Technologies (BSGM), Electromed (ELMD), IRIDEX (IRIX), ENDRA Life Sciences (NDRA), Soleno Therapeutics (SLNO), electroCore (ECOR), Fc Global Realty (FCRE), Viveve Medical (VIVE), Nuwellis (NUWE), Precision Optics (PEYE), Star Equity (STRR), Positron (POSC) and Vaso (VASO).
View all of HSDT's competitors.

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the NASDAQ under the ticker symbol "HSDT."

How do I buy shares of Helius Medical Technologies?

Shares of HSDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Helius Medical Technologies' stock price today?

One share of HSDT stock can currently be purchased for approximately $15.31.

How much money does Helius Medical Technologies make?

Helius Medical Technologies has a market capitalization of $35.47 million and generates $660,000.00 in revenue each year. The company earns $-14,130,000.00 in net income (profit) each year or ($11.80) on an earnings per share basis.

How many employees does Helius Medical Technologies have?

Helius Medical Technologies employs 19 workers across the globe.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is heliusmedical.com.

Where are Helius Medical Technologies' headquarters?

Helius Medical Technologies is headquartered at 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940.

How can I contact Helius Medical Technologies?

Helius Medical Technologies' mailing address is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. The company can be reached via phone at (215) 944-6100 or via email at [email protected]

This page was last updated on 7/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here